PRESLEY PHILLIPS: Open Payments
NPI 1477156719 · ALMA, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$242 in 14 payments from 9 companies in 2025. Trend: 2023 $432 · 2024 $458 · 2025 $242
Food & beverage: $242
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $50 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Exact Sciences Corporation | 2 | $33 |
| ABBVIE INC. | 2 | $30 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Dexcom, Inc. | 1 | $18 |
| Verona Pharma, Inc. | 1 | $17 |
| Novo Nordisk Inc | 1 | $14 |
Products named: EVENITY, VRAYLAR, XIFAXAN, AIRSUPRA, BREZTRI, OTEZLA, CAPLYTA, Dexcom G6 Transmitter.
Industry payments across AR — which companies pay providers there.
